SoftBank Vision Fund sells 4.9m shares of high-flying portfolio firm Guardant Health

REUTERS/Issei Kato

SoftBank Vision Fund shed 4.9 million shares of high-flying Guardant Health Inc. as the fund’s other investments faced valuation and regulatory turmoil.

The Guardant shares were sold for $77 apiece on Wednesday, according to a Friday filing. That’s below the cancer-testing company’s record-high close of $110.30 in August, but still a hefty hike from last year’s $19 initial public offering price. The fund remains Guardant’s largest holder with more than 20 million shares, according to data compiled by Bloomberg.

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter